Published in Eur J Clin Pharmacol on January 01, 1991
Does participation in clinical trials influence the costs of future management of patients? Eur J Health Econ (2011) 0.75
Diffusion of new medicines into hospital practice. Eur J Clin Pharmacol (2003) 0.75
Explanatory model of prescribing behavior in prescription of statins in family practice. Wien Klin Wochenschr (2010) 0.75
Intervention research in rational use of drugs: a review. Health Policy Plan (1999) 2.29
Setting the agenda: does the medical literature set the agenda for articles about medicines in the newspapers? Soc Sci Med (1995) 1.84
Late potentials in a bradycardia-dependent long QT syndrome associated with sudden death during sleep. J Am Coll Cardiol (1992) 1.64
Journalists and their sources of ideas and information on medicines. Soc Sci Med (1994) 1.62
Prescribing quality indicators of type 2 diabetes mellitus ambulatory care. Qual Saf Health Care (2008) 1.61
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther (1974) 1.61
Atherosclerotic plaque rupture: a fatigue process? Med Hypotheses (2000) 1.54
When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines. Clin Pharmacol Ther (2012) 1.49
Interaction of diphenylhydantoin (DPH) and tolbutamide in man. Eur J Clin Pharmacol (1975) 1.46
Nominal shear or fracture mechanics in the assessment of composite-dentin adhesion? J Dent Res (2000) 1.44
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovasc Res (1993) 1.38
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure. J Card Fail (1997) 1.38
[Drug utilization by the elderly with depressive symptoms]. Ned Tijdschr Geneeskd (2001) 1.37
How physicians choose drugs. Soc Sci Med (1988) 1.37
Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J (2000) 1.33
Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe. Eur J Clin Pharmacol (1990) 1.30
Evaluating an educational intervention to improve the treatment of asthma in four European countries. Drug Education Project Group. Am J Respir Crit Care Med (1999) 1.28
Therapeutic decision making of physicians. Pharm Weekbl Sci (1992) 1.27
Towards understanding treatment preferences of hospital physicians. Soc Sci Med (1993) 1.22
Modeling the mechanical behavior of the jaws and their related structures by finite element (FE) analysis. Crit Rev Oral Biol Med (1997) 1.20
Changing doctor prescribing behaviour. Pharm World Sci (1999) 1.20
Mechanical response of nickel-titanium instruments with different cross-sectional designs during shaping of simulated curved canals. Int Endod J (2009) 1.19
Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol (1999) 1.13
Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J Clin Pharmacol (2004) 1.11
Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498. J Cardiovasc Pharmacol (1986) 1.11
Physicians' views on joint treatment guidelines for primary and secondary care. Int J Qual Health Care (2004) 1.07
Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol (1993) 1.06
Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care (2009) 1.03
Can fiber posts increase root stresses and reduce fracture? J Dent Res (2010) 1.02
Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens (1990) 1.01
Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion. Eur J Pharmacol (1984) 1.00
Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol (2002) 0.99
Improving drug treatment in general practice. J Clin Epidemiol (2000) 0.98
Does indirect consultation lead to overprescribing in general practice? Soc Sci Med (1987) 0.98
How does canal taper affect root stresses? Int Endod J (2006) 0.97
Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians. DICP (1990) 0.96
Effects of angiotensin II and captopril on inducible sustained ventricular tachycardia two weeks after myocardial infarction in the pig. J Cardiovasc Pharmacol (1989) 0.95
Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies. Am Heart J (1988) 0.95
Comparison of indicators assessing the quality of drug prescribing for asthma. Health Serv Res (2001) 0.95
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary care. Qual Saf Health Care (2007) 0.95
Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing. Soc Sci Med (2002) 0.94
Sterol balance and cholesterol absorption in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterol. Atherosclerosis (1989) 0.93
Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67. Nuklearmedizin (1976) 0.93
Blood dyscrasias attributed to chloramphenicol. A review of 576 published and unpublished cases. Acta Med Scand (1972) 0.92
In vivo effect of bradykinin during ischemia and reperfusion: improved electrical stability two weeks after myocardial infarction in the pig. J Cardiovasc Pharmacol (1991) 0.92
Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig. J Cardiovasc Pharmacol (1996) 0.92
Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey. Pharmacoepidemiol Drug Saf (2007) 0.90
Prescription changes and drug costs at the interface between primary and specialist care. Eur J Clin Pharmacol (1998) 0.88
Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands. Clin Pharmacol Ther (2012) 0.88
Treatment of uncomplicated urinary tract infections: exploring differences in adherence to guidelines between three European countries. Drug Education Project Group. Ann Pharmacother (2000) 0.88
Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res (1993) 0.88
Analysis of strain gage method for measurement of post-gel shrinkage in resin composites. Dent Mater (1997) 0.88
Effects of 4-aminopyridine in elderly patients with Alzheimer's disease. N Engl J Med (1984) 0.87
Inhibitive effect of a resin-modified glass ionomer cement on remote enamel artificial caries. Caries Res (1997) 0.87
Questions about drugs: how do pregnant women solve them? Pharm World Sci (1994) 0.87
Do low-shrink composites reduce polymerization shrinkage effects? J Dent Res (2011) 0.87
Once daily felodipine in patients with primary Raynaud's phenomenon. Eur J Clin Pharmacol (1991) 0.87
Incremental filling technique and composite material--part II: shrinkage and shrinkage stresses. Oper Dent (2013) 0.87
Relationship between guideline treatment and health-related quality of life in asthma. Eur Respir J (2004) 0.86
Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril. J Cardiovasc Pharmacol (1987) 0.86
Rationalization of incisor shape: experimental-numerical analysis. J Prosthet Dent (1999) 0.86
Drug expectations and drug choices of hospital physicians. J Intern Med (1993) 0.86
The cost of prescription medicines to patients. Health Policy (2000) 0.86
Do physicians take cost into account when making prescribing decisions? Pharmacoeconomics (1995) 0.85
Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model. J Cardiovasc Pharmacol (1987) 0.85
Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden. Qual Saf Health Care (2010) 0.85
Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart. Arch Int Pharmacodyn Ther (1986) 0.84
Plasma levels of acetylsalicylic acid and salicylic acid after oral ingestion of plain and buffered acetylsalicylic acid in relation to bleeding time and thrombocyte function. Pharm Weekbl Sci (1983) 0.84
A study of drug utilization in pregnancy in the light of known risks: is there room for improvement? Int J Risk Saf Med (1990) 0.84
Indicators of quality use of medicines in South-East Asian countries: a systematic review. Trop Med Int Health (2012) 0.84
[Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner]. Ned Tijdschr Geneeskd (2005) 0.84
GPs' treatment of uncomplicated urinary tract infections--a clinical judgement analysis in four European countries. DEP group. Drug Education Project. Fam Pract (1999) 0.83
Specialists' expectations regarding joint treatment guidelines for primary and secondary care. Int J Qual Health Care (2002) 0.83
Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. Clin Sci (Lond) (1988) 0.82
Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects. J Cardiovasc Pharmacol (1993) 0.82
The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. J Neurol Neurosurg Psychiatry (1981) 0.82
Characteristics of non-carious cervical lesions--an ex vivo study using micro computed tomography. J Oral Rehabil (2010) 0.82
The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig. Cardiovasc Drugs Ther (1990) 0.81
The effects of bradykinin and the ischemic isolated rat heart. Horm Metab Res Suppl (1990) 0.81
Basic pharmacology of ACE-inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin. Eur Heart J (1990) 0.81
A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon. Vasa Suppl (1987) 0.81
Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia. J Cardiovasc Pharmacol (1992) 0.81
Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study. Neurology (1986) 0.81
Relationship between plasma concentration and effect of dantrolene sodium in man. Eur J Clin Pharmacol (1979) 0.81
Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl Sci (1991) 0.80
Digoxin-felodipine interaction in patients with congestive heart failure. Eur J Clin Pharmacol (1988) 0.80
Understanding contradictory data in contraction stress tests. J Dent Res (2010) 0.80
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol (1994) 0.80
The haemodynamic effects of two angiotensin converting enzyme inhibitors, enalaprilat and zofenoprilat, in the rat: evidence for the involvement of bradykinin. J Hypertens Suppl (1989) 0.80
Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease. Eur J Clin Pharmacol (1985) 0.80
Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure. J Cardiovasc Pharmacol (1989) 0.80